bpc 157 and multiple sclerosis 544 published articles on BPC-157. 36 met inclusion criteria for a 2025 systematic review. 35 were animal studies. One was clinical. Twelve patients. Seven reported pain relief. No control group. That is Heal or Harm: Body Protective

clinical use typically runs 1226 weeks and is supported up to 52 weeks under medical supervision [3]

Individuals With Persistent Gut Health Concerns: People struggling with irritable bowel syndrome, suspected leaky gut, food sensitivities, or digestive discomfort that has not responded adequately to probiotics, elimination diets, or conventional gastroenterology approaches sometimes explore BPC-157 based on its original research focus on gastric protection and gut lining integrity

BioMed Research International 2021:9924314

Possible mechanisms of homocysteine toxicity

It is a fundamental limitation of preclinical research